Why This BeiGene Analyst Slashes Forecast By Almost 42% - Be

Why This BeiGene Analyst Slashes Forecast By Almost 42% - BeiGene (NASDAQ:BGNE), AbbVie (NYSE:ABBV)

BeiGene Ltd (NASDAQ: BGNE) declined in early trading on Friday, maintaining its downward trajectory through the week amid weakness in Chinese stocks.

Related Keywords

China , Chinese , Rebecca Liang , Beigene Ltd , Beigene Analyst , Market Perform , Beigene Thesis ,

© 2025 Vimarsana